Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Jun 27, 2026
Scholar Rock Holding Corp (SRRK)
A forensic read on Scholar Rock Holding Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Distress
Financial health
-9.9
Altman Z-score
Clean
Earnings quality
2
Forensic signals
-162.9%
ROE
$6.6B
Market cap
Scholar Rock Holding Corp earns a D (Weak — demands caution) forensic quality grade, and its Altman Z-score is -9.9, placing it in the Distress zone. 2 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-1200%Return on invested capital.Return on invested capital is -1200% and slipping from -49% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
+30.8%/yrShare-count dilution.Diluted share count changed +92% over the last 3 years to FY2025 (+30.8%/yr). The count is GROWING — existing holders are being diluted. That's ~30.8% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2022 has been diluted ~92%.
Key fundamentals
Debt / Equity0.41x
Free Cash Flow$-300.6M
Return on Equity-154.0%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Scholar Rock Holding Corp:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about SRRK's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown